spacer
Topic quick links:
Cover page
spacer
All articles in this issue:
New report reveals the latest drug trends in Europe
EMCDDA select new director
Ireland's national suicide strategy 2015-2010, and the evidence base
IMO targets addiction and dependency
CityWide starts debate ahead of UNGASS 2016
Towards UNGASS 2016
Judging prohibition
Misuse of Drugs Amendment) Act 2015
National Drugs Strategy (NDS) 2009-2016: progress in 2014
Benzodiazepine use among young people attending a treatment centre
Treated problem alcohol use in Ireland, NDTRS data 2013
Changes to the NDTRS form for 2016 data collection
Nursing in contexts of marginalised health
Predicting retention in MMT in Ireland
Low-threshold residential stabilisation service (LTRSS) in Ireland
Needle exchange provision in Ireland in 2012
Releasing prisoners early - Community Return
EMCDDA update
Recent publications
Upcoming events
EMCDDA select new director
by Brian Galvin

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has selected Alexis Goosdeel (Belgium) as the agency's new Director, starting on 1 January 2016. Mr Goosdeel, a psychologist with a background in public health, has been head of the EMCDDA's Reitox and international relations unit since 2005. This work involves coordinating a network of 30 national drug monitoring centres and preparing EU candidate and potential candidate countries for membership of the EMCDDA.



The EMCDDA is a special Lisbon-based EU agency. Its aim is to provide the EU and its member states with 'factual, objective, reliable and comparible information at European level concerning drug addiction and their consequences'. The EMCDDA was formally established in 1993 and has been operational since 1995.


Email Software by Newsweaver